Epstein Secrets

sition. Please contact your J.P. Morgan team for additional information. ** Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC FACEBOOK INC-A 04033A-10-0 ARIA 146.59 09062X-10-3 BIIB 18.06 30303M-10-2 FB GS CONT BUFF EQ SPX 7/9/13 80% CONTIN BARRIER- 10.5%CPN 15% CAP

ity Change In Value (3,139,127.75) 11,000.00 1,843,490.00 1,924,553.17 $639,915.42 Current Allocation 12% 1% EFTA01539952 9% 11% 33% US Small/Mid Cap Equity US Large Cap Equity Asset Categories Equity as a percentage of your portfolio - 33 % Account Page 4 of 36 Consolidated Statement Page 7 EFTA01

e position. Please contact your J.P. Morgan team for additional information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC 04033A-10-0 ARIA 130.75 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-07/15/11 MS:21.09 2515A

Equity Change In Value 423,834.75 (70,000.00) 3,428,785.00 (357,603.33) $3,425,016.42 Current Allocation 13% 1% 11% EFTA01539689 17% US Small/Mid Cap Equity 42% Preferred Stocks Concentrated & Other Equity Asset Categories Equity as a percentage of your portfolio - 42 % Account Page 4 of 25 Consol

sition. Please contact your J.P. Morgan team for additional information. ** Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC DEAN FOODS CO FACEBOOK INC-A 04033A-10-0 ARIA 146.37 09062X-10-3 BIIB 16.51 242370-10-4 DF 26.62 30303M-10-2 FB Total US Large Cap Equity $1

51,475.52 65,665.78 Quantity Value Adjusted Tax Cost Original Cost Unrealized Gain/Loss EFTA01540371 Est. Annual Inc. Accrued Div. Yield US Small/Mid Cap Equity DEUTSCHE BK AG LDN BRH 11.79 DBL LONG ETN38 25154H-55-8 DAG 50,000.000 589,500.00 352,529.00 236,971.00 Account W23560001 Page 5 of 32 Cons

e position. Please contact your J.P. Morgan team for additional information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC 04033A-10-0 ARIA 145.83 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-07/15/11 MS:21.09 2515A

o - 34 % Change In Value (189,830.05) 151,500.00 737,667.50 (1,332,662.45) ($633,325.00) Current Allocation 17% 1% EFTA01539867 7% 9% US Small/Mid Cap Equity 34% Preferred Stocks Asset Categories US Large Cap Equity Account Page 4 of 28 Consolidated Statement Page 7 EFTA01539868 FINANCIAL TRUST C

sition. Please contact your J.P. Morgan team for additional information. ** Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC FACEBOOK INC-A GENERAL ELECTRIC CO 04033A-10-0 ARIA 213.02 09062X-10-3 BIIB 41.29 30303M-10-2 FB 23.14 369604-10-3 GE JPM VALUE ADVANTAGE F

.000 307,551.00 290,997.40 16,553.60 Quantity Value Adjusted Cost Original Cost Unrealized Gain/Loss Est. Annual Inc. Accrued Div. Yield US Small/Mid Cap Equity DEUTSCHE BK AG LDN BRH 8.90 DBL LONG ETN38 25154H-55-8 DAG 50,000.000 445,000.00 352,529.00 92,471.00 Account Page 5 of 48 Consolidated St

. ** Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC ASCENA RETAIL GROUP INC 04033A-10-0 ARIA 19.93 COM 04351G-10-1 ASNA BIOGEN IDEC INC FACEBOOK INC-A GENERAL ELECTRIC CO JP MORGAN CHASE & CO JPM VALUE ADVANTAGE FD - INSTL 09062X-10-3 BIIB 50.23 30303M-10-2 FB 23.89 369604-10

47121 SOUTHERN FINANCIAL, LLC ACCT. • For the Period 9/1/13 to 9/30/13 Price US Small Cap Equity APOLLO GLOBAL MANAGEMENT LLC 037612-30-6 APO US Small/Mid Cap Equity DEUTSCHE BK AG LDN BRH DBL LONG ETN38 25154H-55-8 DAG SANGAMO BIOSCIENCES INC Total US Small/Mid Cap Equity 800677-10-6 SGMO $943,000.00 $774

e position. Please contact your J.P. Morgan team for additional information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC FACEBOOK INC-A GENERAL ELECTRIC CO 04033A-10-0 ARIA 218.13 09062X-10-3 BIIB 36.80 30303M-10-2 FB 24.37 369604-10-3 GE JPM VALUE ADVANTAGE F

.000 307,220.30 290,997.40 16,222.90 Quantity Value Adjusted Cost Original Cost Unrealized Gain/Loss Est. Annual Inc. Accrued Div. Yield US Small/Mid Cap Equity DEUTSCHE BK AG LDN BRH 8.44 DBL LONG ETN38 25154H-55-8 DAG P JONES ENERGY INC - A 48019R-10-8 JONE 14.06 0.00 Account Page 5 of 33 Consoli

sition. Please contact your J.P. Morgan team for additional information. ** Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC DEAN FOODS CO FACEBOOK INC-A 04033A-10-0 ARIA 149.09 09062X-10-3 BIIB 17.14 242370-10-4 DF 28.00 30303M-10-2 FB Total US Large Cap Equity $1

1,475.52 118,247.08 Quantity Value Adjusted Tax Cost Original Cost Unrealized Gain/Loss EFTA01540260 Est. Annual Inc. Accrued Div. Yield US Small/Mid Cap Equity DEUTSCHE BK AG LDN BRH 12.48 DBL LONG ETN38 25154H-55-8 DAG 50,000.000 624,000.00 352,529.00 271,471.00 Account W23560001 Page 5 of 43 Cons

e position. Please contact your J.P. Morgan team for additional information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC DEAN FOODS CO FACEBOOK INC-A 04033A-10-0 ARIA 138.21 09062X-10-3 BIIB 16.84 242370-10-4 DF 21.11 30303M-10-2 FB Total US Large Cap Equity $1

344,351.09 (18,000.00) 950,000.00 (2,514,460.00) (1,381,100.84) ($2,619,209.75 ) Current Allocation EFTA01540149 2% 1% 1% 4% 20% 28% US Small/Mid Cap Equity Non-US Equity US Large Cap Equity Preferred Stocks Concentrated & Other Equity Asset Categories Equity as a percentage of your portfolio - 28 %